|Mr. Philip R. Hagerman||Co-Founder & Chairman Emeritus||408.68k||N/A||1952|
|Mr. Gary Rice M.B.A., M.S., R.Ph., RPh, MS, MBA, CSP||Exec. VP of Operations||255.58k||380.54k||1958|
|Mr. Jeffrey G. Park||Interim CEO & Director||N/A||N/A||1972|
|Mr. Joel Saban||Pres||N/A||N/A||1968|
|Mr. Atul Kavthekar||CFO, Treasurer & Principal Accounting Officer||N/A||N/A||N/A|
Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. The company stocks, dispenses, and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. It also provides specialty infusion pharmacy, patient care coordination, clinical, compliance and persistency program, patient financial assistance, specialty pharmacy training/consulting, benefits investigation, prior authorization, risk evaluation and medication strategy, retail specialty, and hub services, as well as clinical and administrative support services to hospitals and health systems. The company's primary focus is on medication management programs for individuals with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialized infusion therapy, and various other serious or long-term conditions. The company was founded in 1975 and is headquartered in Flint, Michigan.
Diplomat Pharmacy, Inc.’s ISS Governance QualityScore as of March 1, 2018 is 6. The pillar scores are Audit: 5; Board: 6; Shareholder Rights: 5; Compensation: 5.